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PENILAIAN KETOKSIKAN SECARA SITO-GENO DENGAN 
MENGGUNAKAN KITOSAN BERGRED BIOPERUBATAN PADA KULTUR 
KERATINOSIT ASAS DAN PERANANNYA DALAM LITAR PEMBENTUKAN 
PARUT DENGAN MENGGUNAKAN MODEL KO-KULTUR KULIT 
 
 
ABSTRAK 
 
 
 Kitosan (-1, 4—D-glukosamin) merupakan kitin yang kumpulan asetilnya telah 
disingkirkan dan ia mempunyai ciri-ciri biologi yang unggul dan berguna dalam rawatan 
luka. Tetapi, pengubahsuaian kitosan secara fizikal dan kimia akan menjejaskan bio-
keserasiannya. Selain daripada itu, dilaporkan juga bahawa kitosan mempunyai 
kegunaan dalam pencegahan parut. Oleh itu dalam kajian ini, dengan menggunakan 
kultur normal keratinosit asas daripada epidermis manusia (pNHEK), bio-keserasian in 
vitro pada templat perbentukan kulit berpori kitosan (CPSRT) yang diubahsuai telah 
dinilai melalui analisis ketoksikan secara sito melalui ujian 3-(4, 5-dimetilthiazol-2-yl)-
2, 5-difenil tetrazolium bromida (MTT), analisis ketoksikan secara geno dengan 
menggunakan ujian komet serta analisis rembesan sitokin keradangan keratinosit kulit 
[interleukin-1 (IL-1), faktor tumor nekrosis- (TNF-) dan interleukin-8 (IL-8)]. 
Peranan CPSRT yang bio-serasi dalam pencegahan keloid telah diselidik dengan 
menggunakan ko-kultur keratinosit-fibroblast. Pengekspresan protein kolagen manusia 
berbentuk-I, III dan V telah diselidik dengan menggunakan analisis Western blot. 
Sementara itu, rembesan faktor pertumbuhan-β1 (TGF- β1) telah dianalisis dengan 
menggunakan ujian enzim-linked immunosorbent (ELISA) dan pengekspresan mRNA 
melalui molekul intraselular (SMAD 2, 3, 4 dan 7) juga telah dihitung dengan 
menggunakan analisis real-time PCR. Kultur keratinosit asas daripada epidermis 
manusia (pHEK) yang selnya berbentuk skuamosa telah disahkan dengan sitokeratin-6 
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(CK6) dan involukrin, manakala kultur fibroblast asas daripada dermis manusia (pHDF) 
telah dibuktikan dengan kewujudan heat shock protein 47 (HSP47) dan protein 
permukaan fibroblast (FSP). CPSRT-NC-bikarbonat telah meningkatkan kadar 
pertumbuhan sel dalam kultur pNHEK. Ia tidak mencetuskan kemusnahan DNA dan 
juga tidak meningkatkan respon sitokin keradangan secara in vitro. Ko-kultur 
keratinosit-fibroblast telah dipelihara dalam DKSFM:DMEM:F12 (2: 2: 1) sebagai satu 
medium yang dikongsi dalam ko-kultur. Kolagen bentuk-I adalah dominan dalam kultur 
normal fibroblast asas daripada dermis manusia (pNHDF) manakala kolagen bentuk-III 
pula banyak didapati dalam ko-kultur fibroblast daripada keloid dermis manusia 
(pKHDF). Kolagen bentuk-V berkemungkinan wujud dengan lebih banyak di dalam 
dermis yang mempunyai kolagen bentuk-I yang banyak. SMAD 2, SMAD 4 dan TGF-
β1 telah didapati lebih banyak di dalam ko-kultur pKHDF berbanding dengan pNHDF. 
Ko-kultur yang wujud dengan keratinosit normal telah mengurangkan pengekspresan 
kolagen bentuk-III, SMAD 2, SMAD 4 dan TGF-β1. Rawatan dengan CPSRT-NC-
bikarbonat meningkatkan lagi kesan itu. Kesimpulannya, CPSRT-NC-bikarbonat yang 
bio-serasi berhubungan dengan kultur normal keratinosit mempunyai bio-fungsi untuk 
mengurangkan fosforilasi TGF-β1 dalam kultur fibroblast yang berasal keloid. Ianya 
mungkin melalui peningkatan dalam pengekspresan SMAD 7 dan faktor-faktor larut 
CPSRT-NC-bikarbonat yang melembapkan reseptor TGF-β, lalu mengurangkan 
transkripsi ekstrasellular matriks (ECM) terutamanya kolagen bentuk-III, di mana ia 
berguna dalam pencegahan keloid. 
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ABSTRACT 
 
 
Chitosan (-1, 4—D-glucosamine) is a deacetylated form of chitin with excellent 
biological properties useful in wound management. However, improvement of the 
physical and chemical properties of the chitosan will alter its biocompatibility. 
Additionally, chitosan has been reported to be useful in scar intervention. Therefore in 
this study, the in vitro biocompatibility of the modified chitosan porous skin 
regenerating templates (CPSRTs) has been evaluated based on cytotoxicity analysis by 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, 
genotoxicity by comet assay, and skin keratinocyte pro-inflammatory cytokine 
secretions  [interleukin-1 (IL-1), tumor necrosis factor- (TNF-) and interleukin-8 
(IL-8)], using primary normal human epidermal keratinocyte (pNHEK) cultures. The 
most biocompatible CPSRT was then investigated for its role in keloid intervention 
using keratinocyte-fibroblast cocultures. The human collagen type-I, III and V protein 
expressions were assayed in Western blot analysis. Meanwhile, the secreted 
transforming growth factor-β1 (TGF-β1) was analyzed by enzyme-linked 
immunosorbent assay (ELISA), and the mRNA expressions of its intracellular signaling 
molecules (SMAD 2, 3, 4 and 7) were quantified using real-time PCR analysis. The 
established squamous-shaped primary human epidermal keratinocyte (pHEK) cultures 
have been verified using cytokeratin-6 (CK6) and involucrin, whereas spindle-shaped 
primary human dermal fibroblast (pHDF) cultures were tested for the presence of heat 
 xxx 
shock protein 47 (HSP47) and fibroblast surface protein (FSP). Treatment with CPSRT-
NC-bicarbonate enhanced the cell growth of pNHEK cultures. It did not induce DNA 
damage and did not provoke pro-inflammatory cytokine responses in vitro. 
Keratinocyte-fibroblast cocultures were maintained in DKSFM: DMEM: F12 (2: 2: 1) as 
a shared serum-free coculture medium. Collagen type-I is the dominant form in primary 
normal human dermal fibroblast (pNHDF) whereas collagen type-III is more abundant 
in primary keloid-derived human dermal fibroblast (pKHDF) cocultures. Collagen type-
V may be present more in the skin dermal that is rich in collagen type-I. SMAD 2 and 
SMAD 4, as well as the TGF-β1 were expressed more in the pKHDF than pNHDF 
cocultures. Cocultures present with normal keratinocytes were observed to suppress 
collagen type-III, SMAD 2, SMAD 4 and TGF-β1 expressions. Treatment with CPSRT-
NC-bicarbonate further enhanced this effect. In conclusion, the biocompatible CPSRT-
NC-bicarbonate which was in association with normal-derived keratinocyte cultures 
exerted bio-functionality to decelerate TGF-β1 phosphorylation in the keloid-derived 
fibroblast culture, perhaps through the increased expressions of SMAD 7 and the soluble 
factors of CPSRT-NC-bicarbonate in deactivating the TGF-β receptors, thus reducing 
transcription of extracellular matrix (ECM) particularly collagen type-III, which can be 
useful in keloid intervention. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1  Research background 
 
 
Wound healing is a process of restoration that is necessary for tissue repair, 
typically comprising a continuous sequence of inflammation and repair in which 
epithelial, endothelial, inflammatory cells, platelets and fibroblasts briefly interact to 
resume their normal functions. This healing process consists of four different and 
overlapping phases, namely: inflammation, granulation tissue formation, matrix 
remodeling and reepithelialization (Christine et al., 1999). The orderly sequence of 
healing events is regulated by various interplayed cytokines and growth factors (Ono 
et al., 1995). One of the ultimate goals in wound healing research involves finding 
ways for humans to heal via the regeneration of similar tissues. This could be 
accomplished via the invention and modification of a variety of dressing materials to 
facilitate proper wound management.  
Chitosan is a partially deacetylated derivative of natural chitin, a primary 
structural polymer in arthropod exoskeletons. One of the present trends in biomedical 
research requires materials that are derived from nature as natural materials have 
been shown to exhibit better biocompatibility with humans. For example, chitosan’s 
monomeric unit, N-acetylglucosamine, occurs in hyaluronic acid, an extracellular 
macromolecule that is important in wound repair. Studies on chitosan have been 
intensified since 1990 due to its low cytotoxicity, antimicrobial activity and excellent 
biodegradable properties in the human body, where these have contributed to the 
better biocompatibility of chitosan (Sashiwa et al., 1990; Shigemasa et al., 1994; 
Van et al., 2006; Prabharan and Mano, 2006). The potential of chitosan stems from 
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its cationic nature and high charge density in solution. An effective approach for 
developing a clinically applicable chitosan is to modify the surface of the material 
that already has excellent biofunctionality and bulk properties. However, blending 
technologies with various additives may cause cytotoxicity. Hence, the modified 
biomedical-grade of chitosan with various derivatives should be submitted for 
biocompatibility testing to promote the engineering of high-quality, biocompatible 
products for human wound management.  
In the pre-commercialization steps of a biomedical-grade chitosan derivative 
as wound dressing, it is of great importance that the dressing be submitted to a 
number of in vitro pre-toxicity assays.  In vitro toxicity examinations are preferable 
to in vivo tests since the newly developed dressing materials can be examined outside 
the body and the results are more reproducible, facilitating clinical evaluation of a 
medicinal product that can be replicated and estimated (Soheili et al., 2003; Cheong 
et al., 2008). Biocompatibility in vitro is useful to characterize cytotoxic effects of 
leachable materials, such as residual monomers, catalysts as well as polymer erosion 
and related factors (e.g. composition, molecular weight and polydispersity) which are 
suitable to monitor the quality and purity of the biodegradable biomedical-grade 
chitosan. Cytotoxicity assays measure only finite effects on cells during the first 12 
to 72 hours after exposure to toxic substances. The host cells either recover from or 
succumb to their chemical injury. However, many biological reactions in vivo are not 
simply cytotoxic and are propagated beyond 24 hours. Examples are improper cells 
programmed apoptosis and necrosis due to deoxyribonucleic acid (DNA) damage; 
inflammatory and immune reactions that all resulted from non-biocompatible 
chitosan derivatives. Therefore, in vitro biocompatibility assessment for wound 
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management must consider cytocompatibility, genotoxicity and related pro-
inflammatory cytokines expression for better in vitro biocompatibility evaluation. 
Abnormal wound healing is related to improper fibroblasts activities in the 
wound bed that have commonly encountered in multiple pathologies ranging from 
diabetic ulcers, to fibrosis and scarring. Keloids render a form of abnormal wound 
healing affecting only human which involve persistent itchy pseudotumoral skin 
lesions expanding beyond edges of the original wounds and frequently recurring 
following surgical excision. The exuberant scarring of keloid leads to disfiguring and 
dysfunctional scars without any satisfactory treatment until today. Hence, by 
understanding the keloid formation pathway may serve as a corner stone for the 
treatment. Unluckily, there are still no keloid studies using established animal model 
(Xia et al., 2004). Alternatively, keloid studies are mostly performed using an in 
vitro model (Uitto et al., 1985; Smith et al., 1999; Higham et al., 2002; Xia et al., 
2004; Naitoh et al., 2005). 
Wound healing is a complex physiological response that involves various 
interactions between epithelial and mesenchymal. Many earlier in vitro studies on 
keloid pathogenesis were largely on the use of keloid fibroblasts simply because it 
mainly produces collagen and extracellular matrix (ECM) that form the bulk of 
keloid tissue. Recently, evidence has indicated that autocrine, paracrine and 
endocrine epithelial-mesenchymal interactions may be involved in normal skin 
homeostasis, growth and differentiation (Maas-Szabowski et al., 1999; Higham et 
al., 2005; Amjad et al., 2007). Therefore, the application of in vitro coculture system 
may serve as a useful tool to elucidate the pathogenesis of keloid. Besides, 
biochemical and ultrastructural studies of the engineered skin via cultures or 
cocultures had also shown the similarities in metabolic and differentiation program 
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compared with human skin (Asbil et al., 2000; Robinson et al., 2000; Wagner et al., 
2001). Human skin tissue culture may provide a controlled yet realistic model to 
study the molecular mechanisms of barrier disruption and identify the involvement of 
genes in a disease development such as scar formation. By using a specifically made 
coculture inserts, that is a membrane with certain pore sizes used to culture one type 
of cell line while the other cell line on another plastic dishes. The combination of 
both inserts will imitate the in vivo-like interactions in which the skin keratinocytes 
are separated from dermal mesenchymal cells by a complex ECM, the basement 
membrane, thus rendering cell-cell contact-mediated mechanisms less probable. 
Fibroblasts are the primary cell type that functions in the organization of the 
ECM following of skin injuries. To restore the barrier function of the skin as quickly 
as possible, closure of skin wounds and replacement of missing skin tissues occur 
rapidly in adult skin by some mechanisms that lead to scarring in which 
overproduction of collagen bundles renders significant keloid pathology. Collagen 
type-I, III and V constitutes a large portion in the keloid ECM (Ala-Kokko et al., 
1987). In accordance with the clinical observation that delayed reepithelialization is 
associated with the scar formation, in vitro investigations have demonstrated that 
keratinocytes decrease fibroblasts expression of collagen and pro-fibrotic factors 
(Garner, 1998; Le Poole and Boyce, 1999). Some have reported that the chitosan 
may be potentially used in scar prevention (Wang et al., 1998; Paul and Sharma, 
2004; Yang et al., 2006; Delorino and Cresidio, 2009). Among the TGF-β isoforms, 
TGF-β1 is one of the most reported and important stimulators of collagen synthesis. 
It affects the ECM not only by stimulating collagen synthesis but also by preventing 
its breakdown (Yang et al., 1997; Szulgit et al., 2002; Quan et al., 2004). TGF-β1 is 
a pro-fibrotic factor that increases the formation of granulation tissue and stimulates 
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wound contraction besides being a negative regulator of inflammation and 
responsible in the switching of the inflammatory phase to the proliferation phase in 
wound healing. Similar to mothers against Decapentaplegic Drosophilia (SMAD) 
proteins function as intracellular signaling mediators of TGF-β family members and 
can be subdivided into receptor-regulated SMADs (R-SMADs), common mediator 
SMADs, and inhibitory SMADs (Ten and Hill, 2004). Kopp et al. (2005) proposed 
the relationship of TGF-β/ SMADs in human fibroproliferative disorders and 
elucidated that autocrine TGF-β/ SMADs signaling is involved in contractility and 
matrix gene expression of the fibroproliferative diseases.  
Therefore, in this study, primary normal human epidermal keratinocytes 
(pNHEK) was implemented in the cytotoxicity pre-evaluation of newly developed 
chitosan porous skin regenerating templates (CPSRTs). Those contributed more than 
70% of cell viability were then chosen for genotoxicity assay using alkaline single 
cell gel electrophoresis (SCGE) or comet assay. Additionally, their potential to 
induce skin irritation or inflammatory responses was assessed by quantitatively 
examining the secretion of pro-inflammatory cytokines (IL-1, TNF- and IL-8) in 
the pNHEK cultures. Keratinocyte-fibroblast coculture model was also constructed 
to study the epithelial-mesenchymal interactions of normal and keloid-derived 
human skin tissues, with regard to the effectiveness of CPSRTs on the keloid 
intervention, by elucidating the expressions of type-I, III and V collagen and its 
response in TGF-β1/ SMADs signaling pathway. 
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1.2   Literature review 
 
1.2.1   Structure and function of human skin 
 
Skin is the largest organ in the human body besides commonly known as a 
vital outpost of the nervous system and is the closest contact with the outside world. 
It naturally provides a protective covering layer for the other tissues in the body, 
acting as a barrier to micro-organisms, water and chemicals, regulating body 
temperature while still maintaining the water content of the body, removing waste 
products from the body and providing sensory information. In addition, the skin 
produces Vitamin D in response to sunlight (Brad Spellberg, 2000). Generally, 
human skin is composed of three structurally and functionally integrated layers 
namely the outer epidermis, the dermis and the inner hypodermis (Haake and 
Holbrook, 2001). 
The human skin epidermis consists mainly of keratinocytes that form a 
stratified squamous epithelium (Eckert et al., 1997). Its thickness is about 0.2 mm on 
average and this thickness varies depending on the location on the body. 
Furthermore, the thickness also varies according to the volume of water that the 
epidermis holds. Epidermal layer itself is further divided under skin cell 
differentiation process into four main layers that are stratum basal, stratum spinous, 
stratum granular and stratum corneum. These layers render to different stages of cell 
maturation. Keratinocytes at the basal layer progressively differentiate upward into 
cells with morphologically bigger and flatter-shaped meanwhile loosing proliferative 
ability (Jetten and Harvat, 1997).  Epidermal population of stem cells that are 
confined to the basal cell layer of the epidermis will constitutively provide the 
epidermis with its regenerative capacity. Cells from the basal layer migrate and 
replicate during reepithelialization of wound healing (Haake and Holbrook, 2001). 
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Basal layer keratinocytes are columnar in shape and adhere with the underlying 
basement membrane through the hemidesmosomes. In the outermost layer which is 
stratum corneum, cells are cornified, lacking nuclei and organelles besides composed 
primarily of keratins. The cornified cells desquamate in order to balance the 
proliferation in the basal layer at the turnover rate of approximately 21 days. There 
are also small portions of cells residing in the human skin epidermal namely 
pigment-producing melanocytes, antigen-presenting Langerhans cells and 
neuroendocrine Merkel cells. The epidermal appendages (hair follicles, apocrine 
glands, sweat glands and sebaceous glands) extend into the human skin dermis. In 
superficial wounds where most of the dermis is intact and viable, the cells in the 
epidermal appendages proliferate and regenerate the epidermis (Fairley, 2001). 
The dermis is the second layer of human skin, beneath the epidermal layer. 
This layer is much thicker than the epidermis ranging from 1 to 4 mm. The dermis is 
structurally organized into the uppermost papillary and the innermost reticular 
dermis. At the dermal-epidermal junction, the dermal papillae interact with 
extensions of the epidermis called rete pegs. The sub-papillary plexus which is lying 
as horizontally vessels constitutes the boundary between the papillary and reticular 
regions besides extending capillaries toward the skin epidermis (Haake and 
Holbrook, 2001). The skin dermis has few cells and is mainly composed of 
connective tissue and extracellular matrix (ECM) (Lee et al., 2006). The essential 
dermal cell type is fibroblast which is responsible for the production and 
maintenance of the structural elements of skin. These elements are collagen and 
elastin which are the major fibrous components in the reticular dermis, combining 
with non-fibrous substances such as glycosaminoglycans (GAGs) to form ECM 
(Butler et al., 1999). Fibroblasts are more abundant in the papillary dermis and have 
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higher proliferative and metabolic activity at this location.  Collagen is the major 
constituent accounting approximately 75% of the dry weight of human skin. There 
are several types of collagen present in mammalian skins. Collagen type-I, III and V 
commonly are found in human in which normal skin dermal consists approximately 
80% of collagen type-I. The connective tissues of the dermis give the skin its 
pliability, elasticity, tensile strength and protect the body from mechanical injuries 
(Brown et al., 1994). During deep wound healing, skin dermal fibroblasts are 
responsible for the formation of scar tissue accompanied with activated immune 
response and reparative processes. 
Hypodermis is a layer underneath the dermis which is an abrupt transition 
from the reticular dermis. This layer is rich in adipose tissue. However, skin dermis 
and hypodermis are integrated through nerve and vascular networks as well as 
epidermal appendages. The adipocytes are organized into lobules separated by septa 
of connective tissues that contain nerves, vessels and lymphatics (Wajchenberg, 
2002). This hypodermis insulates the human body, provides energy and allows for 
mobility of the skin on underlying structures. Adipose tissue that is underlying the 
hypodermis serves as an energy storage, in which is virtually limitless via lipogenesis 
over lipolysis and pre-adipocyte replication and differentiation (Prins and O’Rahilly, 
1997). 
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1.2.2 Cutaneous wound healing 
Wound is defined as the disruption of the anatomic structures and their 
functions in any body parts. This can be due to a simple cut or burns. Wounds can be 
generally classified as wounds without tissue loss (e.g. in surgery) and wounds with 
tissue loss such as burn wounds, wounds due to trauma, abrasions or as secondary 
events in chronic ailments (e.g. venous stasis, diabetic ulcers and iatrogenic wounds 
such as skin graft donor sites and derma-brasions) (Willi and Chandra, 2004). In 
contrast, wound healing is a process of restoration by which tissue repair takes place 
and usually comprises of a continuous sequence of inflammation and reparation in 
which epithelial, endothelial, inflammatory cells, platelets and fibroblasts briefly 
interact to restore a semblance of their usual discipline and resume their normal 
functions. The orderly sequence of healing events are accomplished and regulated by 
cytokines and growth factors (Ono et al., 1995). Wound healing is a process 
involving generally three phases namely inflammation, proliferation and tissue 
remodeling. Soon after the elimination of macrophage that appears during the 
inflammatory phase, wound healing is then impeded and the tensile strength of the 
scar is diminished (Leibovich and Ross, 1975).  
 
1.2.2.1  Inflammation phase 
Cutaneous injury disrupts primarily the blood vessels and lymphatics. An 
initial five to ten minutes period of vasoconstriction is then followed by more 
persistent vasodilatation. This presents itself as erythema, swelling, warmth and is 
often accompanied with pain. Blood components are recruited into wound cavity. 
Endothelial cells retract and loose their attachments with adjoining cells, exposing 
subendothelial factor VII related Von Willebrand factor and fibrillar collagen in the 
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injured tissue. Platelets adhere to these surfaces to form platelet plug, with 
association of fibrin clot provides a protective wound matrix. The provisional matrix 
composed of fibrin and small amounts of vitronectin, fibronectin and 
thrombospondin. Platelets release inflammatory mediators that together with 
bacterial peptides and products of matrix degradation attract leukocytes to the 
wound. Neutrophil migrations engulf debris and microorganisms providing the first 
line of defense against infection for a few days. If acute inflammation phase persists 
due to wound hypoxia, infection, nutritional deficiencies or other factors related to 
one’s immune response, it can interfere with the late inflammatory phase 
(Stadelmann et al., 1998). Macrophages replace neutrophils towards the end of the 
inflammatory phase. Macrophages release several growth factors that stimulate the 
migration of proliferation of fibroblasts as well as the production of ECM. 
Thrombocytopenia decreases inflammatory activity during wound healing but it does 
not impede cutaneous tissue repair (Szpaderska et al., 2003). 
 
1.2.2.2  Proliferation phase 
The subsequent proliferation phase is dominated by the formation of 
granulation tissue and reepithelialization. Chemotactic and growth factors released 
from platelets and macrophages stimulate the migration and activation of wound 
fibroblasts that produce a variety of substances such as glycosaminoglycans (mainly 
hyaluronic acid, chondroitin-4-sulfate, dermatan sulfate and heparin sulfate) and 
collagen (Stadelmann et al., 1998). This amorphous and gel-like connective tissue 
matrix is necessary for cell migration. Reepithelialization begins where the basal 
keratinocytes flatten and detach from the basement membrane and migrate over the 
wound matrix. There is also evidence that suprabasal keratinocytes take part in the 
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reepithelialization (Laplante et al., 2001). Fibronectin, laminin 5 and collagen type I 
that reside in the ECM are known to assist the keratinocytes migration while collagen 
type IV, thrombospondin and laminin may inhibit the migration (Frank and Carter, 
2004; Woodley et al., 1991). Antimicrobial peptide LL37 has also been regarded as 
one of the factors involved in the reepithelialization (Heilborn et al., 2003). Matrix 
degrading enzymes are highly increased in wound healing and facilitate the 
migration of keratinocytes (Pilcher et al., 1999).  
During the end of migratory phase of keratinocytes and where the 
components of basement membrane begin to aggregate, the migration is terminated 
leading subsequently to the proliferation and differentiation of keratinocytes to 
reconstitute the epidermis. Epidermal reconstitution requires migration, proliferation, 
differentiation and stratification of keratinocytes in cutaneous wound healing 
(Laplante et al., 2001). Interactions between skin keratinocytes and fibroblasts in 
regulating basement membrane formation, cell proliferation and differentiation in 
vitro, may probably occur in vivo (Smola et al., 1998). Dermal fibroblasts may 
promote reepithelialization by secreting keratinocyte growth factor (KGF), insulin 
growth factor-1 (IGF-1) and the epidermal growth factor family (Haase et al., 2003; 
Werner and Smola, 2001). There is accumulating evidence for a possible role of 
interleukin-1 in reepithelialization (Werner and Smola, 2001; Maas-Szabowski et al., 
2000). Thus, hypertrophic scar formation in wounds due to delayed 
reepithelialization suggests a role for keratinocytes in diminishing the production of 
ECM by fibroblasts. 
The dermal component of the wound heals through matrix synthesis 
(fibroplasia) and wound contraction, which is a centripetal movement of the edges of 
a full thickness wound in order to facilitate closure of the defect (Grillo, 1964). 
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Blood vessels are formed in the process of angiogenesis. Collagen synthesis and 
cross-linkage is responsible for vascular integrity and strength of new capillary beds. 
Improper cross-linkage of collagen fibers has been reported in nonspecific post-
operative bleeding in patients with normal coagulation parameters (Blee et al., 2002). 
Fibroblasts and endothelial cells proliferate and start to migrate into the wound about 
48 hours after injury in which fibroblasts form the new connective tissue while 
endothelial cells give rise to new vessels. Some fibroblasts differentiate into 
myofibroblasts that are characteristically similar to both smooth muscle cells and 
fibroblasts. Singer (1979) has described such a specialized structure as the 
‘fibronexus’ which associates across the cytoplasmic membrane of the 
myofibroblasts of intracellular actin microfilaments and extracellular fibronectin 
fibers. Therefore, contraction of the actin filaments within the myofibroblasts will 
lead to the fibronexus to transmit this force to the surrounding matrix and mediate 
the clinical phenomenon of wound contraction that aids in closing the wound.  
 
1.2.2.3  Tissue remodeling  
Tissue remodeling is the final stage of cutaneous wound healing which 
continues for months after injury. The events in remodeling are responsible for the 
increase in tensile strength, decrease in erythema and formation of scar tissue bulk 
with the final appearance of the healed scar. As collagen is laid down, fibronectin 
gradually disappears. The nonsulfated glycosaminoglycans and hyaluronic acid are 
replaced by more resilient proteoglycans such as chondroitin-4-sulfate. Additionally, 
re-absorption of water from the scar allows the collagen fibers and other matrix 
components to lie closer together leading to an increase in the tensile strength.  A 
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matrix rich in collagen type-I replaces the provisional matrix and granulation tissue 
which are rich in fibronectin and collagen type-III (Guo et al., 1990).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14
1.2.3  Chitosan as wound dressing 
Wound dressings are generally classified based on its nature of action as 
passive products, interactive products and bioactive products. Traditional dressings 
such as gauze and tulle dressings that account for the largest market segment are 
known as passive products. Polymeric films and forms which are mostly transparent, 
permeable to water vapor and oxygen but impermeable to bacteria are commonly 
recognized as interactive products. Bioactive dressings are important in delivering 
substances in wound healing by which the delivery of bioactive compounds or 
dressings is constructed from material having endogenous activity. These materials 
include proteoglycans, collagen, non-collagenous proteins, alginates or chitosan 
(Willi and Chandra, 2004). 
Chitosan is an N-deacetylated derivative bio-product of chitin and is found in 
the cell walls of some fungi (e.g. Basidiomycetes spp.), arthropods and marine 
invertebrates. Chitosan is usually produced from chitin by alkali treatment (Roller 
and Covill, 1999). Commercial chitosan is commonly deacetylated greater than 70% 
of deacetylation with molecular weights ranging between 100 000 to 1.2 million 
dalton (Onsoyen and Skaugrud, 1990). Chitosan is polycationic at pH < 6 and 
interacts readily with negatively charged substances such as protein, anionic 
polysaccharides (e.g. alginate, carragenan), fatty acids, bile acids and phospholipids 
due to the high density of amino groups present in the polymer (Muzzarelli, 1996). 
Their unique properties include polyoxysalt formation, the ability to form films, 
chelate metal ions and optical structural characteristics (Larry, 1998). Most of the 
current polymers are synthetic materials. Their biocompatibility and biodegradability 
are much more limited than chitosan and their derivatives. However, these naturally 
abundant materials also exhibit a limited reactivity and processing ability (Mass et 
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al., 1998). Chitosan’s positive surface charge enables it to effectively support cell 
growth (Zileinski and Acbischer, 1994).  
Chitosan is well known for its haemostatic properties to prevent excessive 
bleeding, while its biological activities can mediate macrophage function to secrete 
numerous enzymes (e.g. collagenase) and cytokines [e.g. interleukins, tumor necrosis 
factor (TNF)] in wound healing processes. Its biological properties include 
bacteriostatic and fungistatic which are particularly useful for wound treatment 
(Majeti and Ravi, 2000). It appears that chitosan which has structural characteristics 
similar to glycosamino glycans, could be considered for developing such substratum 
for skin replacement. Yannas et al. (1982) proposed a design of artificial skin for 
long term chronic use, focusing on a non-antigenic membrane in which can perform 
as a biodegradable template for the synthesis of neodermal tissue.  According to Yao 
et al. (1994), chitosan can be used as an artificial skin in accelerating wound and 
ulcer healing besides serving as a biocompatible vehicle for sustained release of 
drug. Recently, application of chitosan has been given serious research attention due 
to its potentially important renewable resource that is non-toxic and biodegradable. 
Malette et al. (1986) studied the effect of treatment with chitosan and saline solution 
on healing and fibroplasia of wounds made by scalpel insertions in skin and 
subcutaneous tissue in the abdominal surface of dogs. It has been suggested that 
chitosan may be used to inhibit fibroplasia in wound healing and to promote tissue 
growth and differentiation in tissue culture (Muzzarelli et al., 1997). Some have 
reported that the chitosan may be potentially used in scar prevention (Wang et al., 
1998; Paul and Sharma, 2004; Yang et al., 2006). Delorino and Cresidio (2009) 
concluded that by using 10% lactic acid for decalcification and 1M NaOH for 
deproteination chitosan is effective as active ingredient in scar remover cream. 
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Schmidt et al. (1993) have also reported the properties of chitosan in preventing 
overgrowth of fibroblasts besides being cytocompatible (Risbud et al., 2000) and 
blood biocompatible (Risbud and Bhat, 2001). The excellent biological properties of 
chitosan can be potentially improved with a variety of additional chemicals such as 
polyethylene glycol and carboxymethyl, N-acyl groups in order to produce 
biocompatible chitosan derivatives for use as wound dressing (Zhang et al., 2002). 
Chitosan-gelatin sponge wound dressing had shown better antibacterial effect by 
vacuum dryness on Escherichia coli K88 than that of penicillin besides having the 
superior healing effect to that by 0.2% (v/v) ethacridine. Additionally, chitosan-
gelatin sponge assisted the wound contraction and shortened the wound healing time 
compared with sterile Vaseline gauze (Deng et al., 2007). Clinical assessment was 
performed using a Hyphecan cap (1-4,2-acetamide-deoxy-β-D-glucan), as a 
biological fingertip dressing and was proven to be effective in achieving a good 
functional and cosmetic result within a relatively short time, aside from being 
comfortable during conventional dressing changes (Halim et al., 1996).  
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1.2.4 Biocompatibility in vitro of biomedical-grade chitosan 
Biocompatibility of a biomedical-grade chitosan refers to the quality of the 
material that does not have toxic or injurious effects on biological systems. 
Biocompatibility of any biomaterials is necessary to be tested for their strength, 
esthetics and clinical manipulation. Current regulations in accordance with the 
United States Food and Drug Administration (FDA), the International Organization 
for Standardization (ISO) and the Japanese Ministry of Health and Welfare (JMHW) 
require that manufacturers conduct adequate safety testing of their finished devices 
through pre-clinical and clinical phases as part of the regulatory clearance process. 
Toxicity induced by a chemical substance or drug can exert limitation on dose and 
duration of treatment besides adversely affecting patients’ quality of life and may be 
life threatening. Side effects together with tissue toxicity will lead to long term 
effects such as alteration to the immune system and development of malignancies 
probably due to genetic damage induced by a certain kind of drug treatment (Paola et 
al., 2002). In the pre-commercialization steps of any biomaterial, it is of importance 
to undergo a number of pre-toxicity tests in vitro or in vivo. In vitro toxicity 
examinations are more favorable over the in vivo tests since the newly developed 
biomaterials can be examined outside the body and the results are more reproducible. 
Thus, preliminary in vitro tests are always being carried out to pre-screen and 
characterize the potentially harmful effects of a newly synthesized dressing material 
before it is clinically used on humans (Zhang et al., 2002). However, in vitro tests 
may not necessarily fully represent the in vivo test whereby differences in 
sensitivities had been observed between primary and established cell lines (Geurtsen 
et al., 1998; Lovschall et al., 2002). Various in vitro cell culture systems have been 
applied to investigate and evaluate the cellular processes, such as fibroblast and 
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keratinocyte proliferation and migration response to the growth factors that are 
present in a wound (Schreier et al., 1993; Cha et al., 1996; Kawada et al., 1997). 
Such in vitro models simplify and enable chemicals and biomaterials to be assessed 
for their potential, at least in a preliminary way, to promote wound repair by 
stimulating cell proliferation and for their biocompatibility.  
Chitosan is a cationic polymer having an amino group in its chemical 
structure. Its anti-tumor, anti-microbial and anti-inflammatory properties can be 
largely attributed to the cationic structure. The N-acetylglucosamine moiety in 
chitosan is structurally similar to glycosaminoglycans (GAGs), heparin, chondroitin 
sulphate and hyaluronic acid in which they are biocompatible, and have specific 
interactions with various growth factors, receptors and adhesion proteins besides 
being the biologically important mucopolysaccharides in all mammals. Therefore, 
the analogous structure in chitosan may also exert similar bioactivity and 
biocompatibility (Li et al., 1992; Suh and Matthew, 2000). Additionally, chitosan 
can function as a bridge to improve the mechanical strength of collagen-based 
scaffolds owing to the large number of amino groups in its molecular chain (Taravel 
and Domard, 1996). Lee et al. (2002) performed trypan blue dye exclusion 
cytotoxicity assay on tumor cell lines, after increased positive charge density of 
chitosan by dialkylaminoalkylation and reductive amination followed by 
quaternization. Amino groups of chitosan attached with biologically active moieties 
such as vanillin, p-hydroxybenzaldehyde, p-chlorobenzaldehyde, anisaldehyde, 
methyl 4-hydroxybenzoate, methyl 2,4-dihydroxybenzoate, propyl 3,4,5-
trihydroxybenzoate and 2-hydroxymethylbenzoate can promote anti-microbial ability 
(Kenaway et al., 2005).  
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A thorough understanding of cell and protein interactions with artificial 
surfaces is of importance to design suitable implant surfaces and substrates. The 
surface properties of newly synthesized biomedical-grade chitosan derivatives, 
including surface composition, wettability, domain composition, surface oxidation, 
surface charge and morphology, may influence protein adsorption and subsequently, 
the cellular responses to biomaterial implants. Though it has once been suggested 
that surfaces modified with polyethylene glycol (PEG) may limit protein adsorption 
and cell adhesion, the results for PEG blended with chitosan increased both 
adsorption and cell adhesion (Saneinejad and Shoichet, 1998). Peng et al. (2006) 
demonstrated that chitosan-collagen composites appeared as a biocompatible 
biomaterial for periodontal tissue engineering. Zhang et al. (2002) examined the 
biocompatibility of newly synthesized chitosan-PEG by growing and observing the 
morphological changes of 3T3 embryonic mouse fibroblasts and osteogenesis nodule 
cell suspension in culture. Cytotoxicity of chitosan in three dimensional fiber meshes 
was well determined with scanning electron microscopy (SEM) and cell 
morphological observation on the use of mouse lung fibroblast (L929) (Tuzlakoglu et 
al., 2004). Recent studies have been focused on the development of antibacterial 
surfaces of biomedical-grade chitosan derivatives to attain high functionality and 
high-value products. Huh et al. (2001) prepared chitosan-grafted poly(ethylene 
terepthalate) (PET) and quaternized chitosan-grafted PET, both showed high growth 
inhibition in the range of 75% to 86% and still retained 48% to 58% bacterial growth 
inhibition after laundering. But, higher antibacterial activity of a wound dressing can 
retard cell growth in culture. Laminin is known to be involved in metastasis of tumor 
cells. A peptide containing the Tyrosine-Isoleucine-Glycine-Serine-Arginine [Tyr-
Ile-Gly-Ser-Arg (YIGSR)] sequence, corresponding to a partial sequence of laminin, 
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inhibited angiogenesis and therefore depressed tumor growth. Nishiyama et al. 
(2000) prepared YIGSR-chitosan conjugate which proved to have higher inhibitory 
activity against experimental lung metastasis of B16BL6 melanoma cells in mice 
than did the parent peptide. According to Koo et al. (2002), water-soluble chitosan 
(WSC) significantly protected the cultured cells from serum starvation-induced 
cellular rounding up and from serum starvation-induced cell death through p53 
activation as tested by flow-cytometry and western blot. From these results, it 
appears that WSC may prevent serum starvation-induced apoptosis of human 
astrocytes via p53 inactivation. Cross-linking will increase the toxicity of chitosan 
scaffold leachate to fibroblast cells. However, the chitosan crosslinked with dimethyl 
3-3,dithio-bis’propionimidate (DTBP) permitted cell proliferation after three days in 
culture (Adekogbe and Ghanem, 2005).  
Denuziere et al. (1998) examined the cytocompatibility of films of chitosan 
and chitosan associated with GAGs in human skin keratinocytes and found that the 
cell growth was consistently to approximate 60% of that of controls. Highly 
deacetylated chitosans can modulate human skin cell mitogenesis in vitro. Cell 
compatibility of N-sulfoalkylchitosan derivatives with human dermal fibroblasts 
(HDFs) was dependent on the concentration of sulfonate moieties in which higher 
concentration led to decrease in cell compatibility (Jung et al., 2007). Additionally, 
Zainol et al. (2008) described the usefulness of chitosan to be developed into porous 
bilayer membrane as a skin regenerating template for treatment of third degree burn, 
and was also proven to be cytocompatible for skin fibroblasts as the cultured cells 
were noticed to proliferate on the chitosan membrane. Analysis of their effects on 
cells in culture may be useful as a screening tool for their potential activity in vivo as 
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wound healing agents. But, it is important to select appropriate strains of cells for use 
in the in vitro biocompatibility screening (Howling et al., 2001). 
 
1.2.4.1  Cytocompatibility assessment in vitro 
One of the most basic and important parameters in the in vitro measurement 
of a medicinal product’s biocompatibility is cytocompatibility in vitro, which 
measures the qualitative and quantitative aspects of the impact of a medicinal 
product with regard to the viability of target cultured cells. There are a number of 
assays which are capable of evaluating the activation of biological processes (e.g. 
inflammation, immune reactions and mutagenesis) which require longer periods of 
tissue reaction to materials compared with cytotoxic reactions. Traditional assays 
have measured cytotoxicity in vitro by means of either an end-stage event (e.g. 
permeability of cytoplasmic membranes of dead and dying cells, or some metabolic 
parameters such as cell division or an enzymatic reaction) (Hanks et al., 1996). 
Cytotoxicity assays are commonly used to indicate the only finite effects on cells 
during the exposure to toxic substances at multiple concentrations and time course 
parameters. The colorimetric 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium 
bromide (MTT) assay is a simple assay which is selected to determine detrimental 
intracellular effects on mitochondria and metabolic activity based on the selective 
ability of viable cells to reduce tetrazolium bromide into purple formazan crystals 
which are only soluble in organic solvents. The quantity of formazan crystal formed 
depends on intact metabolic activity and is frequently used for screening of 
cytotoxicity (Mossman, 1983). In vitro biocompatibility evaluation of biomedical-
grade oligo-chitosan (O-C) and N, O- carboxymethyl-chitosan (NO-CMC) 
derivatives (O-C 1%, O-C 5%, NO-CMC 1% and NO-CMC 5%) correlated well 
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with in vivo study in which O-C 1% being the most cytocompatible using MTT cell 
viability assay. The experiment was carried out as described by the International 
Standards Organization (ISO), with some modifications (Lim et al., 2007). The MTT 
assessment of cytocompatibility was adequately good and the results were easily 
interpreted, besides being cost effective (Mori et al., 1997; Chellat et al., 2000; 
Janvikul et al., 2005; Mei et al., 2005; Neamnark et al., 2007). 
Appropriate target cell to be cultured should be in accordance with the end 
usage of a newly synthesized biomaterial. Je et al. (2006) suggested that chitosan 
derivatives in their studies were specific to tumor cell lines [HeLa (cervix cancer), 
HT108 (human fibrosarcoma) and A549 (lung cancer)]. Several transformed 
keratinocyte culture models have been used to study carcinogenesis, differentiation, 
apoptosis and cell cycle regulation (Yuspa et al., 1994). L929 mouse fibroblast cell 
line was often applied to evaluate cytotoxicity in vitro of various chitosan derivatives 
(Mori et al., 1997; Janvikul et al., 2005). Zange et al. (1998) implemented the MTT 
assay to pre-screen the cytotoxicity of poly(L-lactic-co-glycolic acid) attached with 
poly(ethylene oxide), namely ABA triblocks by using L929 mouse fibroblast cell 
lines and proved the better sensitivity of in vitro model for the cytotoxicity 
evaluation than studies in experimental animal model. Peng et al. (2006) observed 
the cell viability of human periodontal ligament cells (PDLCs) seeded within the 
chitosan-collagen scaffolds by using MTT assay and proved that chitosan-collagen 
composites are promising scaffold materials for periodontal tissue engineering. 
Others such as F1000 embryonic skin and muscle fibroblasts (Chung et al., 1994) 
were also implemented for the cytotoxicity evaluation. Cytotoxicity of chitosan with 
various degrees of N-deacetylation to form aminoethyl-chitosan, dimetylaminoethy-
chitosan and diethylaminoethyl-chitosan, was examined with MTT on tumor cell 
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lines and concluded that cytotoxic effect may be caused by cationic charge of the 
chitosan derivatives (Je et al., 2006). Howling et al. (2001) had successfully 
demonstrated the use of human skin dermal fibroblasts and epidermal keratinocytes 
to evaluate the effect of chitosan with various deacetylation levels and polymer 
lengths in vitro. Jung et al. (2007) explored the cytocompatibility of newly 
synthesized N-sulfopropylchitosan derivatives by using MTT assay on human dermal 
fibroblasts (HDF) culture and suggested the usefulness of MTT assay together with 
the use of other cell types in assessing the cytocompatibility of chitosan derivatives. 
HDFs cultures were also implemented along with MTT cell viability assay to 
examine the cell proliferation within the newly developed chitosan-based porous 
scaffold (Lim et al., 2007).  
 
1.2.4.2  Genotoxicity assessment in vitro 
Although measures of a medical product's biocompatibility have largely been 
reported in terms of irritation, sensitization, and systemic toxicity, there is a growing 
concern that devices or biomaterial extracts may exert some genotoxic effects. Thus, 
any attempts to assess the safety of a device intended for intimate body contact or 
permanent implantation would be incomplete without testing for the presence of 
toxins that might exert an effect on the genetic material of cells. In its set of 
harmonized standards for the biological evaluation of medical devices, the ISO has 
outlined the need for such genotoxicity testing in ISO 10993-3: "Tests for 
Genotoxicity, Carcinogenicity, and Reproductive Toxicity."   
A number of techniques for detecting deoxyribonucleic acid (DNA) damage 
as opposed to the biological effects (e.g. Ames test, micronuclei, mutations, 
structural chromosomal aberrations) (Ames et al., 1973; Savage, 1976; Ishidate, 
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1979; Maron and Ames, 1983) that result from DNA damage have been used to 
identify substances with genotoxic activity. According to Muramatsu et al. (2004), 
they did not detect any genotoxicity via Ames test and chromosome aberration assay, 
performed on Chinese hamster lung fibroblasts with 5mg/ml (maximum 
concentration) of beta-tricalcium phosphate/carboxymethyl-chitin. Abou Sereih et al. 
(2007) reported that their chitosan with concentrations of 3.00 and 4.50 mg/ml have 
induced mutation on Trichoderma. However, those techniques have some 
shortcomings (e.g. time consuming, requirement for proliferating cell populations) 
(Fernandez and Ferrao, 1999; Giri et al., 1999; Ikken et al., 1999; Umbuzeiro et al., 
1999).  
Until recently, a more useful approach for assessing DNA damage is the 
single-cell gel electrophoresis (SCGE) or comet assay. The terms “Comet” is used to 
identify the individual cell DNA migration patterns produced. According to Ostling 
and Johanson (1984), they were the first to develop a microgel electrophoresis 
technique for detecting DNA damage at the single cell level. In their technique, cells 
were embedded in agarose and placed on a microscope slide. The cells were lysed by 
detergents and high salt concentration to liberate the DNA. The liberated DNA was 
then electrophoresed under neutral conditions. Therefore, cells with an increased 
frequency of DNA double strand breaks (DSB) displayed increased migration of 
DNA toward the anode. The migrating DNA was then measured quantitatively by 
staining with ethidium bromide using a microscope photometer. The neutral 
condition used in the comet assay detects only DSB of a cell. Subsequently, Singh et 
al. (1988) introduced a microgel technique involving electrophoresis under alkaline 
(pH >13) conditions for detecting DNA single strand breaks (SSB) and alkali-labile 
sites (ALS) in single cells. Singh (2000) mentioned that the alkaline comet assay can 
